Study title: Naproxen, ibuprofen, and placebo dosing compliance study in natural common colds
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NAPROXEN | |||||
ATC code: | |||||
Document link: Bayer CC_Naproxen Sodium_CC-01242_study_synopsis.pdf | |||||
Document date: 2011-09-15 | |||||
Study number: CC-01242 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |